|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clinc. 64:9–29. 2014. View Article : Google Scholar
|
|
2
|
Steeq PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fidler IJ: The pathogenesis of cancer
metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Iorio MV and Croce CM: MicroRNAs in
cancer: Small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mendell JT: MicroRNAs: Critical regulators
of development, cellular physiology and malignancy. Cell Cycle.
4:1179–1184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gibborns DL, Lin W, Creiqhton CJ, Rizvi
ZH, Gregory PA, Goodall GJ, Thilaganathan N, Du L, Zhang Y,
Pertsemlidis A and Kurie JM: Contextual extracellular cues promote
tumor cell EMT and metastasis by regulating miR-200 family
expression. Genes Dev. 23:2140–2151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ceppi P, Mudduluru G, Kumarswamy R, Rapa
I, Scagliotti GV, Papotti M and Allgayer H: Loss of miR-200c
expression induces an aggressive, invasive, and chemoresistant
phenotype in non-small cell lung cancer. Mol Cancer Res.
8:1207–1216. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Zhao W, Bao P, Li C, Ma XQ, Li Y and
Chen LA: miR-339-5p inhibits cell migration and invasion in
vitro and may be associated with the tumor-node-metastasis
staging and lymph node metastasis of non-small cell lung cancer.
Oncology Lett. 8:719–725. 2014.
|
|
12
|
Kang Y and Massagué J:
Epithelial-mesenchymal transitions: Twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sobin LH, Gospodrowicz MK and Wittekind C:
International Union against Cancer: TNM Classification of Malignant
Tumours. 7th edition. Wiley-Blackwell; New York, NY: 2011
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang X, Zhu J, Xing R, Tie Y, Fu H, Zheng
X and Yu B: miR-513a-3p sensitizes human lung adenocarcinoma cells
to chemotherapy by targeting GSTP1. Lung Cancer. 77:488–494. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fan Z, Cui H, Xu X, Lin Z, Zhang X, Kang
L, Han B, Meng J, Yan Z, Yan X and Jiao S: miR-125a suppresses
tumor growth, invasion and metastasis in cervical cancer by
targeting STAT3. Oncotarget. 6:25266–25280. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bourguignon LY, Spevak CC, Wong G, Xia W
and Gilad E: Hyaluronan-CD44 interaction with protein kinase
C(epsilon) promotes oncogenic signaling by the stem cell marker
Nanog and the production of microRNA-2, leading to down-regulation
of the tumor suppressor protein PDCD4, anti-apoptosis, and
chemotherapy resistance in breast tumor cells. J Biol Chem.
284:26533–26546. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y and
Zheng X: miR-34a inhibits migration and invasion by down-regulation
of c-Met expression in human hepatocellular carcinoma cells. Cancer
Lett. 275:44–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Valastyan S, Reinhardt F, Benaich N,
Calogrias D, Szász AM, Wang ZC, Brock JE, Richardson AL and
Weinberg RA: A pleiotropically acting microRNA, miR-31, inhibits
breast cancer metastasis. Cell. 137:1032–1046. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang K, Handorean AM and Iczkowski KA:
MicroRNAs 373 and 520c are downregulated in prostate cancer,
suppress CD44 translation and enhance invasion of prostate cancer
cells in vitro. Int J Clin Exp Pathol. 2:361–369. 2009.PubMed/NCBI
|
|
22
|
Rhoads K, Arderiu G, Charboneau A, Hansen
SL, Hoffman W and Boudreau N: A role for Hox A5 in regulating
angiogenesis and vascular patterning. Lymphat Res Biol. 3:240–252.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen Y and Gorski DH: Regulation of
angiogenesis through a microRNA (miR-130a) that down-regulates
antiangiogenic homeobox genes GAX and HOXA5. Blood. 111:1217–1226.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fabbri M, Garzon R, Cimmino A, Liu Z,
Zanesi N, Callegari E, Liu S, Alder H, Costinean S,
Fernandez-Cymering C, et al: MicroRNA-29 family reverts aberrant
methylation in lung cancer by targeting DNA methyltransferases 3A
and 3B. Proc Natl Acad Sci USA. 104:15805–15810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bracken CP, Gregory PA, Khew-Goodall Y and
Goodall GJ: The role of microRNAs in metastasis and
epithelial-mesenchymal transition. Cell Mol Life Sci. 66:1682–1699.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gregory PA, Bracken CP, Bert AG and
Goodall GJ: MicroRNAs as regulators of epithelial-mesenchymal
transition. Cell Cycle. 7:3112–3118. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma L and Weinberg RA: Micromanagers of
malignancy: Role of microRNAs in regulating metastasis. Trends
Genet. 24:448–456. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Park SM, Gaur AB, Lengvel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hurteau GJ, Carlson JA, Spivack SD and
Brock GJ: Overexpression of the microRNA hsa-miR-200c leads to
reduced expression of transcription factor 8 and increased
expression of E-cadherin. Cancer Res. 67:7972–7976. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chang CC, Ye BH, Chaganti RS and
Dalla-Favera R: BCL-6, a POZ/zinc-finger protein, is a
sequence-specific transcriptional repressor. Proc Natl Acad Sci
USA. 93:6947–6952. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Polo JM, Dell'Oso T, Ranuncolo SM,
Cerchietti L, Beck D, Da Silva GF, Prive GG, Licht JD and Melnick
A: Specific peptide interference reveals BCL6 transcriptional and
oncogenic mechanisms in B-cell lymphoma cells. Nat Med.
10:1329–1335. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Phan RT, Saito M, Basso K, Niu H and
Dalla-Favera R: BCL6 interacts with the transcription factor Miz-1
to suppress the cyclin-dependent kinase inhibitor p21 and cell
cycle arrest in germinal center B cells. Nat Immunol. 6:1054–1060.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jardin F, Ruminy P, Bastard C and Tilly H:
The BCL6 proto-oncogene: A leading role during germinal center
development and lymphomagenesis. Pathol Biol (Paris). 55:73–83.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu ZS, Wu Q, Wang CQ, Wang XN, Wang Y,
Zhao JJ, Mao SS, Zhang GH, Zhang N and Xu XC: miR-339-5p inhibits
breast cancer cell migration and invasion in vitro and may be a
potential biomarker for breast cancer prognosis. BMC Cancer.
10:5422010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao X, Duan Z, Liu X, Wang B, Wang X, He
J, Yao Z and Yang J: MicroRNA-127 is downregulated by Tudor-SN
protein and contributes to metastasis and proliferation in breast
cancer cell line MDA-MB-231. Anat Rec (Hoboken). 296:1842–1849.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pinto AE, André S, Silva G, Vieira S,
Santos AC, Dias S and Soares J: BCL-6 oncoprotein in breast cancer:
Loss of expression in disease progression. Pathobiology.
76:235–242. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hirata Y, Ogasawara N, Sasaki M, Mizushima
T, Shimura T, Mizoshita T, Mori Y, Kubota E, Wada T, Tanida S, et
al: BCL6 degradation caused by the interaction with the C-terminus
of pro-HB-EGF induces cyclin D2 expression in gastric cancers. Br J
Cancer. 100:1320–1329. 2009. View Article : Google Scholar : PubMed/NCBI
|
